Evaluation of Potential Anti-Diabetic Synbiotic Formulation of Lacticaseibacillus rhamnosus BST.L-601 Using db/db Mice
Hyewon Choe, Chae Young Shin, Jung Sik Lim, Jung-Soo Park, Joo-Woong Park, Woo Jung Kim, Yong Il Park, Jin Ree · 2025
Read Evaluation of Potential Anti-Diabetic Synbiotic Formulation of Lacticaseibacillus rhamnosus BST.L-601 Using db/db Mice by Hyewon Choe, Chae Young Shin, Jung Sik Lim, Jung-Soo Park, Joo-Woong Park, Woo Jung Kim, Yong Il Park, Jin Ree (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12731962.txt.
Description
Hyewon Choe and seven co-authors test a probiotic mix for diabetes in mice in a 2025 study. Friendly gut bacteria are being explored as gentle aids for chronic disease. The strain used here was paired with sweet potato as a fermentation partner to form a combined product.
The sweet potato medium raised production and shelf stability of the bacteria. In muscle cell tests, heat-killed bacteria lifted glucose uptake and slowed a sugar-breaking enzyme without harming cells. Diabetic mice dosed for eight weeks showed lower fasting glucose and stronger expression of glucose handling genes in muscle. Blood markers backed the improvement picture. The study supports synbiotic products as candidate aids beside standard diabetes care.
Catalog record
| CREATOR | Hyewon Choe, Chae Young Shin, Jung Sik Lim, Jung-Soo Park, Joo-Woong Park, Woo Jung Kim, Yong Il Park, Jin Ree |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |